NCT05256563Active, not recruiting
A Biomarker for Personalized Care in Post-Stroke Spatial Neglect
Source: ClinicalTrials.gov · Last updated 3 Feb 2026
Brief summary (registry, in English)
More than 30,000 Veterans are hospitalized for stroke each year, and in the critical first months of recovery, at least half are disabled by abnormal 3-D spatial function (spatial neglect). Their self-care, mobility, and ability to return home are severely limited.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 45 (actual)
- First submitted
- 15 Feb 2022
- Start date
- 1 Sept 2021
- Primary completion date
- 31 Jul 2026
- Lead sponsor
- VA Office of Research and Development
- Diseases
- Stroke
- NCT number
- NCT05256563
What you commit to
- Study type: Observational
- Participants enrolled: 45
- From 1 Sept 2021 to the primary completion date, 31 Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Chronic neurological disorders
Other
- Other serious
- Evidence of other serious strokes
- Inability to undergo testing or give informed consent
Who the study is looking for
- Stroke survivors \>18 years
- 1-8 months post-stroke
- Can undergo testing and give informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Atlanta VA Medical and Rehab Center, Decatur, GA Coordinator of this site? Confirm its status | Decatur | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.